Who
Susan L. Kelley
Director
Company insider
Files Form 4 as: Director, Dare Bioscience; Director, Deciphera Pharmaceuticals; Director, IDEAYA Biosciences; Director, Arqule; Director, Immune Design.
In numbers
- Trades disclosed
- 66
- Buys
- 1
- Sells
- 0
- Bought
- $60K
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 27 Apr 2011
- Last trade
- 30 Jun 2026
- Last filed
- 2 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jun 2026filed 2 Jul 2026 | DARE Dare BioscienceBiotechnology | SEC FORM 4 Code A | —23,696 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | DARE Dare BioscienceBiotechnology | SEC FORM 4 Code A | —23,696 at $0.00 | filing |
| 11 Jun 2026filed 11 Jun 2026 | DARE Dare Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 11 Jun 2026filed 11 Jun 2026 | DARE Dare Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 9 Jul 2025filed 10 Jul 2025 | DARE Dare Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,500 at $0.00 | filing |
| 11 Jun 2024filed 11 Jun 2024 | Deciphera Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —24,000 | filing |
| 11 Jun 2024filed 11 Jun 2024 | Deciphera Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —9,570 | filing |
| 11 Jun 2024filed 11 Jun 2024 | Deciphera Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —18,500 | filing |
| 11 Jun 2024filed 11 Jun 2024 | Deciphera Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —3,269 | filing |
| 11 Jun 2024filed 11 Jun 2024 | Deciphera Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —30,000 | filing |
| 5 Jun 2024filed 7 Jun 2024 | DARE Dare Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 31 May 2024filed 31 May 2024 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,200 at $0.00 | filing |
| 21 Jun 2023filed 23 Jun 2023 | Deciphera Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 21 Jun 2023filed 21 Jun 2023 | DARE Dare Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 7 Jun 2023filed 9 Jun 2023 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,200 at $0.00 | filing |
| 17 Jan 2023filed 19 Jan 2023 | Deciphera Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | $50K3,269 at $15.30 | filing |
| 23 Jun 2022filed 24 Jun 2022 | Deciphera Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —18,500 at $0.00 | filing |
| 23 Jun 2022filed 24 Jun 2022 | DARE Dare Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,000 at $0.00 | filing |
| 9 Jun 2022filed 10 Jun 2022 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,000 at $0.00 | filing |
| 9 Jun 2022filed 10 Jun 2022 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.